Related Experiment Videos
Carvedilol: therapeutic application and practice guidelines
B E Bleske1, E M Gilbert, M A Munger
1University of Michigan College of Pharmacy, Ann Arbor, USA.
Insights
Carvedilol, a beta-blocker, effectively reduces mortality and disease progression in heart failure patients when added to standard treatments. It is well-tolerated and improves quality of life, with clinical guidelines available for its use.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Heart failure progression is linked to neurohormonal activation and impaired myocardial energetics.
- Therapies targeting these mechanisms offer significant benefits.
Purpose of the Study:
- To evaluate the efficacy and tolerability of carvedilol in heart failure management.
- To provide clinical guidelines for carvedilol use.
Main Methods:
- Carvedilol, a nonselective beta-adrenergic blocker with vasodilating properties, was administered to heart failure patients.
- Outcomes assessed included mortality, disease progression, and quality of life.
Main Results:
- Carvedilol addition to standard therapy significantly reduced mortality.
- The drug slowed heart failure progression and improved patient quality of life.
- Carvedilol was well-tolerated when administered per guidelines.
Conclusions:
- Carvedilol is a beneficial therapy for heart failure, improving survival and quality of life.
- Adherence to recommended guidelines ensures good tolerability.
- Clinical guidelines are provided to support optimal use of carvedilol.
Abstract:
Current knowledge of the mechanisms contributing to progression of heart failure suggests that therapies that limit or interfere with the consequences of neurohormonal activation and improve myocardial energetics appear to be most beneficial. Carvedilol, a nonselective beta-adrenergic blocker with peripheral vasodilating properties, reduces mortality, slows progression of disease, and improves quality of life in patients with heart failure when added to standard therapy. When administered according to recommended guidelines, carvedilol is well tolerated. Clinical guidelines on the use of carvedilol in heart failure are provided.